Literature DB >> 22096466

Intracamaral bevacizumab in neovascular glaucoma with scleromalasia and retinal detachment.

Suleyman Ciftci1.   

Abstract

Entities:  

Year:  2009        PMID： 22096466      PMCID： PMC3028004          DOI： 10.1136/bcr.02.2009.1633

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


× No keyword cloud information.
  3 in total

1.  Intracameral bevacizumab for iris rubeosis.

Authors:  Salvatore Grisanti; Sabine Biester; Swaantje Peters; Olcay Tatar; Focke Ziemssen; Karl Ulrich Bartz-Schmidt
Journal:  Am J Ophthalmol       Date:  2006-07       Impact factor: 5.258

2.  Rapid improvement of rubeosis iridis from a single bevacizumab (Avastin) injection.

Authors:  Frederick H Davidorf; J Garret Mouser; Robert J Derick
Journal:  Retina       Date:  2006-03       Impact factor: 4.256

Review 3.  Vascular endothelial growth factor: basic science and clinical progress.

Authors:  Napoleone Ferrara
Journal:  Endocr Rev       Date:  2004-08       Impact factor: 19.871
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.